Notably, our current study reveals that elevated WBC levels and the presence of the WT1 mutation are predictive of poorer EFS in childhood AML, whereas CEBPA mutation, as well as the presence of inv(16) and t(8;21) karyotypic abnormalities, are indicative of a more favorable prognosis. The gene discussed is WT1; the disease is acute myeloid leukemia.